COVID-19 took control of the markets - Wednesday Review, June 24

By: Miguel A. Rodriguez

09:45, 14 September 2020

1593071509.jpg
Markets ended on the negative territory as the number of infections keeps on rising.

The US

The American benchmarks recorded the worst session they had in two weeks, as States reported a sharp increase in the number of COVID-19 infections. USA30 fell 2.7%. USA500 shed 2.6%, while TECH100 snapped out of the record gains it had the previous day and ended on -2.2%.

Oil prices fell almost 6% after data from EIA showed an increase in shale oil. Oil lost 5.8% to $38.01 per barrel, while Brent shed 5.4% to $40.31.

The Dollar Index rose 0.48% to 96.07.

Gold broke the winnings chain and fell 0.4% to $1,775.10 per ounce.  


Asia and Australia

Even though the number of infections continues to increase, the market paid attention to tensions between China, Hong Kong, and Macau, as the National People's Congress Standing Committee is set to meet this weekend. The security law could be enforced before July in Hong Kong and Macau.

HongKong45 was down 0.05%.

Japan225 gained 0.02%, while USD/JPY peaked to 106.97.

Down Under, ASX rose 0.11%. AUD/USD dropped to the lowest point it had in two weeks – 0.6865.


Europe

The European benchmarks closed lower yesterday as new outbreaks have been reported, and various areas are again in lockdown. Germany30 led the losses as it dropped by 0.8%. UK100 fell 0.7%, while France40 was down 0.6%.

EUR/USD slid 0.1% to 1.1300. 

GBP/USD fell 0.76% to $1.2422.

Are you always on the move? Don't worry! Download our app, and stay informed!

Sources: marketwatch.com, investing.com


Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.